Apiam Selling And Marketing Expenses vs Interest Income Analysis

AHX Stock

0.42 0.01 2.33%

Apiam Animal financial indicator trend analysis is way more than just evaluating Apiam Animal Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Apiam Animal Health is a good investment. Please check the relationship between Apiam Animal Selling And Marketing Expenses and its Interest Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apiam Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling And Marketing Expenses vs Interest Income

Selling And Marketing Expenses vs Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Apiam Animal Health Selling And Marketing Expenses account and Interest Income. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Apiam Animal's Selling And Marketing Expenses and Interest Income is 0.88. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Interest Income in the same time period over historical financial statements of Apiam Animal Health, assuming nothing else is changed. The correlation between historical values of Apiam Animal's Selling And Marketing Expenses and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Apiam Animal Health are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Selling And Marketing Expenses i.e., Apiam Animal's Selling And Marketing Expenses and Interest Income go up and down completely randomly.

Correlation Coefficient

0.88

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Selling And Marketing Expenses

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most indicators from Apiam Animal's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Apiam Animal Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apiam Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 109.5 M in 2025, whereas Tax Provision is likely to drop slightly above 1.5 M in 2025.

	2022	2023	2024	2025 (projected)
EBITDA	17.1M	23.5M	27.1M	28.4M
Other Operating Expenses	184.9M	157.9M	181.6M	117.5M

Ebitda Other Operating Expenses

Apiam Animal fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Stockholder Equity	Total Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Deferred Long Term Liab	Short Long Term Debt Total	Net Tangible Assets	Property Plant And Equipment Net
Total Assets		0.98	0.97	1.0	0.72	0.65	0.3	-0.24	0.36	0.45	0.81	0.32	0.13	-0.14	1.0	0.7	-0.11	0.77	0.55	0.31	0.39	0.84	0.77	0.5	-0.53	0.51
Other Current Liab	0.98		0.99	0.97	0.66	0.69	0.18	-0.2	0.32	0.5	0.77	0.37	0.22	-0.15	0.99	0.64	-0.16	0.81	0.57	0.28	0.43	0.78	0.79	0.54	-0.58	0.55
Total Current Liabilities	0.97	0.99		0.96	0.64	0.69	0.17	-0.15	0.41	0.5	0.78	0.35	0.24	-0.27	0.97	0.63	-0.19	0.87	0.61	0.35	0.44	0.77	0.77	0.52	-0.56	0.52
Total Stockholder Equity	1.0	0.97	0.96		0.76	0.61	0.35	-0.28	0.42	0.39	0.85	0.28	0.07	-0.12	0.98	0.74	-0.08	0.76	0.5	0.3	0.34	0.87	0.73	0.45	-0.48	0.46
Other Liab	0.72	0.66	0.64	0.76		0.02	0.8	-0.69	0.48	-0.29	0.91	-0.37	-0.51	0.2	0.68	1.0	0.52	0.37	-0.04	0.07	-0.34	0.98	0.21	-0.19	0.17	-0.16
Retained Earnings	0.65	0.69	0.69	0.61	0.02		-0.38	0.21	0.03	0.87	0.32	0.87	0.66	-0.3	0.67	-0.01	-0.8	0.73	0.65	0.15	0.74	0.2	0.93	0.94	-0.9	0.93
Accounts Payable	0.3	0.18	0.17	0.35	0.8	-0.38		-0.7	0.26	-0.61	0.59	-0.6	-0.81	0.47	0.25	0.81	0.68	-0.14	-0.41	-0.13	-0.63	0.71	-0.17	-0.49	0.47	-0.45
Cash	-0.24	-0.2	-0.15	-0.28	-0.69	0.21	-0.7		-0.21	0.51	-0.58	0.48	0.71	-0.66	-0.2	-0.69	-0.52	0.12	0.61	0.6	0.62	-0.6	0.14	0.37	-0.39	0.35
Other Assets	0.36	0.32	0.41	0.42	0.48	0.03	0.26	-0.21		-0.14	0.56	-0.26	-0.2	-0.34	0.31	0.47	0.15	0.47	0.07	0.22	-0.03	0.45	-0.07	-0.2	0.18	-0.23
Long Term Debt	0.45	0.5	0.5	0.39	-0.29	0.87	-0.61	0.51	-0.14		-0.04	0.93	0.79	-0.41	0.5	-0.32	-0.82	0.57	0.79	0.29	0.93	-0.1	0.81	0.94	-0.97	0.91
Net Receivables	0.81	0.77	0.78	0.85	0.91	0.32	0.59	-0.58	0.56	-0.04		-0.09	-0.31	0.02	0.78	0.9	0.21	0.6	0.14	0.12	-0.14	0.94	0.44	0.1	-0.08	0.1
Good Will	0.32	0.37	0.35	0.28	-0.37	0.87	-0.6	0.48	-0.26	0.93	-0.09		0.73	-0.23	0.37	-0.39	-0.87	0.39	0.62	0.13	0.83	-0.19	0.8	0.98	-0.95	0.97
Inventory	0.13	0.22	0.24	0.07	-0.51	0.66	-0.81	0.71	-0.2	0.79	-0.31	0.73		-0.64	0.18	-0.52	-0.78	0.52	0.73	0.41	0.81	-0.36	0.51	0.7	-0.68	0.67
Other Stockholder Equity	-0.14	-0.15	-0.27	-0.12	0.2	-0.3	0.47	-0.66	-0.34	-0.41	0.02	-0.23	-0.64		-0.15	0.2	0.39	-0.64	-0.75	-0.81	-0.51	0.12	-0.18	-0.23	0.26	-0.18
Total Liab	1.0	0.99	0.97	0.98	0.68	0.67	0.25	-0.2	0.31	0.5	0.78	0.37	0.18	-0.15		0.66	-0.15	0.78	0.58	0.32	0.43	0.81	0.8	0.54	-0.58	0.55
Long Term Investments	0.7	0.64	0.63	0.74	1.0	-0.01	0.81	-0.69	0.47	-0.32	0.9	-0.39	-0.52	0.2	0.66		0.53	0.35	-0.06	0.07	-0.36	0.98	0.19	-0.21	0.19	-0.19
Short Long Term Debt	-0.11	-0.16	-0.19	-0.08	0.52	-0.8	0.68	-0.52	0.15	-0.82	0.21	-0.87	-0.78	0.39	-0.15	0.53		-0.41	-0.49	-0.07	-0.75	0.37	-0.61	-0.82	0.76	-0.8
Total Current Assets	0.77	0.81	0.87	0.76	0.37	0.73	-0.14	0.12	0.47	0.57	0.6	0.39	0.52	-0.64	0.78	0.35	-0.41		0.74	0.52	0.55	0.5	0.68	0.53	-0.54	0.49
Short Term Debt	0.55	0.57	0.61	0.5	-0.04	0.65	-0.41	0.61	0.07	0.79	0.14	0.62	0.73	-0.75	0.58	-0.06	-0.49	0.74		0.8	0.8	0.12	0.67	0.68	-0.74	0.65
Intangible Assets	0.31	0.28	0.35	0.3	0.07	0.15	-0.13	0.6	0.22	0.29	0.12	0.13	0.41	-0.81	0.32	0.07	-0.07	0.52	0.8		0.42	0.15	0.22	0.17	-0.23	0.15
Common Stock	0.39	0.43	0.44	0.34	-0.34	0.74	-0.63	0.62	-0.03	0.93	-0.14	0.83	0.81	-0.51	0.43	-0.36	-0.75	0.55	0.8	0.42		-0.16	0.63	0.8	-0.86	0.79
Property Plant Equipment	0.84	0.78	0.77	0.87	0.98	0.2	0.71	-0.6	0.45	-0.1	0.94	-0.19	-0.36	0.12	0.81	0.98	0.37	0.5	0.12	0.15	-0.16		0.39	0.0	-0.02	0.03
Deferred Long Term Liab	0.77	0.79	0.77	0.73	0.21	0.93	-0.17	0.14	-0.07	0.81	0.44	0.8	0.51	-0.18	0.8	0.19	-0.61	0.68	0.67	0.22	0.63	0.39		0.9	-0.88	0.9
Short Long Term Debt Total	0.5	0.54	0.52	0.45	-0.19	0.94	-0.49	0.37	-0.2	0.94	0.1	0.98	0.7	-0.23	0.54	-0.21	-0.82	0.53	0.68	0.17	0.8	0.0	0.9		-0.97	0.99
Net Tangible Assets	-0.53	-0.58	-0.56	-0.48	0.17	-0.9	0.47	-0.39	0.18	-0.97	-0.08	-0.95	-0.68	0.26	-0.58	0.19	0.76	-0.54	-0.74	-0.23	-0.86	-0.02	-0.88	-0.97		-0.96
Property Plant And Equipment Net	0.51	0.55	0.52	0.46	-0.16	0.93	-0.45	0.35	-0.23	0.91	0.1	0.97	0.67	-0.18	0.55	-0.19	-0.8	0.49	0.65	0.15	0.79	0.03	0.9	0.99	-0.96

Click cells to compare fundamentals

Apiam Animal Account Relationship Matchups

Apiam Animal fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	157.3M	199.2M	246.0M	255.8M	230.2M	181.6M
Other Current Liab	10.9M	14.7M	16.9M	20.4M	18.4M	13.1M
Total Current Liabilities	24.4M	28.8M	33.3M	33.7M	30.4M	24.5M
Total Stockholder Equity	79.8M	108.6M	117.9M	122.0M	109.8M	94.9M
Other Liab	1.3M	2.1M	4.7M	4.8M	4.3M	4.1M
Retained Earnings	11.6M	13.8M	15.3M	18.5M	21.2M	22.3M
Accounts Payable	6.2M	5.7M	6.3M	6.1M	5.5M	7.6M
Cash	2.2M	2.8M	3.2M	1.8M	2.0M	1.8M
Long Term Debt	34.9M	39.2M	66.1M	64.3M	57.8M	45.7M
Net Receivables	13.5M	13.6M	14.0M	13.4M	12.0M	16.3M
Good Will	86.5M	113.3M	145.3M	150.1M	172.6M	181.3M
Inventory	16.0M	17.8M	15.5M	15.1M	17.4M	12.7M
Other Stockholder Equity	(112.6M)	(141.0M)	(150.2M)	(1.0)	(0.9)	(0.94)
Total Liab	76.5M	90.5M	128.1M	133.7M	120.4M	86.3M
Long Term Investments	220K	271K	274K	273K	245.7K	233.4K
Short Long Term Debt	3.4M	2.8M	2.9M	2.9M	2.6M	2.5M
Total Current Assets	33.3M	35.9M	34.7M	32.5M	29.3M	29.0M
Short Term Debt	5.7M	6.5M	7.9M	5.9M	5.3M	5.1M
Intangible Assets	95.3M	126.9M	163.6M	17.5M	20.1M	19.1M
Common Stock	101.0M	127.2M	134.8M	135.8M	122.2M	94.5M
Property Plant Equipment	19.8M	24.5M	31.6M	43.8M	39.4M	37.5M
Deferred Long Term Liab	2.1M	2.0M	1.5M	3.3M	3.8M	4.0M
Short Long Term Debt Total	55.0M	63.4M	98.0M	101.8M	117.0M	122.9M
Net Tangible Assets	(14.7M)	(13.2M)	(16.8M)	(42.4M)	(38.2M)	(36.3M)
Property Plant And Equipment Net	25.0M	31.6M	43.8M	51.0M	58.7M	61.6M
Net Debt	52.9M	60.5M	94.9M	100.0M	115.0M	120.8M
Non Current Assets Total	124.0M	163.3M	211.3M	223.3M	256.8M	269.6M
Non Currrent Assets Other	(86.5M)	(113.3M)	(145.3M)	17.5M	15.7M	16.5M
Cash And Short Term Investments	2.2M	2.8M	3.2M	1.8M	2.0M	2.3M
Common Stock Shares Outstanding	124.0M	138.1M	177.8M	182.0M	209.3M	132.7M
Liabilities And Stockholders Equity	157.3M	199.2M	246.0M	255.8M	294.1M	160.4M
Non Current Liabilities Total	52.1M	61.7M	94.9M	100.0M	115.0M	120.8M
Other Current Assets	2.8M	1.6M	2.1M	2.2M	2.6M	2.0M
Property Plant And Equipment Gross	41.5M	54.8M	72.8M	85.4M	98.2M	103.1M
Accumulated Other Comprehensive Income	(32.8M)	(32.5M)	(32.3M)	(32.2M)	(37.0M)	(38.9M)
Current Deferred Revenue	16K	19K	1.2M	1.8M	2.0M	2.1M
Long Term Debt Total	45.0M	49.3M	56.9M	90.1M	103.6M	108.8M
Capital Lease Obligations	17.3M	21.3M	29.0M	37.5M	43.1M	45.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Apiam Stock Analysis

When running Apiam Animal's price analysis, check to measure Apiam Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apiam Animal is operating at the current time. Most of Apiam Animal's value examination focuses on studying past and present price action to predict the probability of Apiam Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apiam Animal's price. Additionally, you may evaluate how the addition of Apiam Animal to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC